Niagen Bioscience, Inc.
NAGENasdaqCIK 1386570HealthcareFiscal year ends Dec 31
Reports and events: 366 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0416:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001386570-26-000043 |
| 2026-08-0416:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-26-000042 |
| 2026-06-2916:30 ET | 8-K | 5.07 Shareholder vote results | 0001386570-26-000035 |
| 2026-05-0616:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-26-000031 |
| 2026-05-0616:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001386570-26-000030 |
| 2026-04-2916:02 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001386570-26-000022 |
| 2026-03-1908:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001386570-26-000017 |
| 2026-03-0416:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-26-000014 |
| 2026-03-0416:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001386570-26-000013 |
| 2026-02-2607:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001386570-26-000003 |
| 2025-12-2208:32 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000030 |
| 2025-11-0609:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001386570-25-000025 |
| 2025-11-0416:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000021 |
| 2025-11-0416:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001386570-25-000020 |
| 2025-10-0616:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000015 |
| 2025-08-0616:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000011 |
| 2025-08-0616:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001386570-25-000010 |
| 2025-07-2916:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-036445 |
| 2025-06-2716:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-033302 |
| 2025-05-0716:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-023129 |
| 2025-05-0716:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023127 |
| 2025-04-2916:18 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001628280-25-020690 |
| 2025-03-1908:32 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-013681 |
| 2025-03-0416:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-009785 |
| 2025-03-0416:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-009774 |
| 2025-02-2716:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-008691 |
| 2024-12-1616:00 ET | 8-K | 4.01 Change of auditor | 0001628280-24-051374 |
| 2024-12-0417:26 ET | 8-K | 8.01 Other events | 0001628280-24-049951 |
| 2024-11-2116:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-048830 |
| 2024-10-3116:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-044541 |
| 2024-10-3116:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044540 |
| 2024-10-1116:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-24-042724 |
| 2024-09-2008:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-040982 |
| 2024-08-2106:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-204003 |
| 2024-08-2106:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-204002 |
| 2024-08-0716:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-035593 |
| 2024-08-0716:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035591 |
| 2024-07-1616:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-031955 |
| 2024-06-2517:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-029936 |
| 2024-06-2417:28 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-029643 |
| 2024-05-0816:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-021648 |
| 2024-05-0816:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021645 |
| 2024-04-2516:01 ET | DEF 14A | Proxy statementPeriod 2024-04-25 | 0001628280-24-018138 |
| 2024-03-0616:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-009383 |
| 2024-03-0616:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-009380 |
| 2023-12-1316:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-23-041428 |
| 2023-11-0816:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-037816 |
| 2023-11-0816:01 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-037809 |
| 2023-09-0706:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-230038 |
| 2023-08-0916:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-028555 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.